Replies to post #18083 on Momenta Pharmaceuticals, Inc. (MNTA)

[DewDiligence]

There is no phase-1 PK trial for M710 because the drug is given by intravitreal injection and there is no ethical way to measure PK within the eye. So, the first trial of M710 will be a phase-3 that evaluates efficacy and safety in AMD patients.